The basic principle in the Biocidal Products Regulation ((EU) No 528/2012 (BPR)) is that a biocidal product (BP) must be authorised before it can be made available on the market or used in the European Union (EU)/ European Economic Area (EEA).
This takes place in two consecutive steps. As the first step, the active substance is evaluated and, provided the criteria are fulfilled, is then approved in a specified product-type (PT). The second step is the authorisation of each BP consisting of, containing or generating the approved active substance(s).
This document concerns the first step, approval of active substances.
October 2016
Collegati
EU - JRC, 17.03.2022
The EU Chemicals Strategy for Sustainability (CSS) aims at fostering a transition towards safe and sustainable chemicals. To e...
ID 14792 | 08.09.2023 / Download Scheda
La Convenzione di Rotterdam (Convenzione PIC - Prior Informed Consent), adottata nel 1998 ed ...
Disaster risk prevention can be regarded as a facet and as a result of sustainable development.
Standards help businesses and organizations progress towards all t...
Testata editoriale iscritta al n. 22/2024 del registro periodici della cancelleria del Tribunale di Perugia in data 19.11.2024
